Any DNA to Declare? Regulating Offshore Access to Genetic Enhancement
This Article begins by briefly addressing in Part II why GE should receive special consideration from a theoretical perspective in light of the many other biotechnologies that have raised concern. In Part III, it explores the multiple forms that GE might take and delineates the threats GE poses to the United States. Part IV analyzes traditional methods of enforcement used both in the United States and abroad that might apply to GE regulation. Part V discusses the difficulties in enforcing such restrictions in the United States and abroad. Finally, Part VI concludes that while a completely effective ban on offshore access to GE is improbable, the United States should still strive to regulate GE abroad because of the threats it presents to society.
Place of Original Publication
American Journal of Law & Medicine
28 American Journal of Law and Medicine 179 (2002)
Mehlman, Maxwell J. and Rabe, Kristen M., "Any DNA to Declare? Regulating Offshore Access to Genetic Enhancement" (2002). Faculty Publications. 843.
This document is currently not available here.